Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.

Angiopoietin-2 (Ang-2) is a key mediator of pulmonary vascular permeability. This study tested the association between plasma Ang-2 and mortality in pediatric acute respiratory distress syndrome (ARDS), with stratification for prior hematopoietic cellular transplantation (HCT), given the severe, yet poorly understood, ARDS phenotype of this subgroup. We enrolled 259 children <18 years of age with ARDS; 25 had prior HCT. Plasma Ang-2, von Willebrand Factor antigen (vWF), and vascular endothelial growth factor (VEGF) were measured on ARDS days 1 and 3 and correlated with patient outcomes. Day 1 and day 3 Ang-2 levels were associated with mortality independent of age, sex, race, and P/F ratio [odds ratio (OR) 3.7, 95% CI 1.1-11.5, P = 0.027; and OR 10.2, 95% confidence interval (CI) 2.2-46.5, P = 0.003, for each log10 increase in Ang-2]. vWF was associated with mortality (P = 0.027), but VEGF was not. The association between day 1 Ang-2 and mortality was independent of levels of both vWF and VEGF (OR 3.6, 95% CI 1.1-12.1, P = 0.039, for each log10 increase in Ang-2). 45% of the cohort had a rising Ang-2 between ARDS day 1 and 3 (adjusted mortality OR 3.3, 95% CI 1.2-9.2, P = 0.026). HCT patients with a rising Ang-2 had 70% mortality compared with 13% mortality for those without (OR 16.3, 95% CI 1.3-197.8, P = 0.028). Elevated plasma levels of Ang-2 were associated with mortality independent of vWF and VEGF. A rising Ang-2 between days 1 and 3 was strongly associated with mortality, particularly in pediatric HCT patients, suggesting vulnerability to ongoing endothelial damage.

[1]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[2]  C. Dvorak,et al.  New Insights Into Multicenter PICU Mortality Among Pediatric Hematopoietic Stem Cell Transplant Patients* , 2015, Critical care medicine.

[3]  Christopher L. Carroll,et al.  Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[4]  G. Bernard,et al.  Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. , 2014, Chest.

[5]  H. Haller,et al.  Lung-Targeted RNA Interference Against Angiopoietin-2 Ameliorates Multiple Organ Dysfunction and Death in Sepsis , 2014, Critical care medicine.

[6]  D. Chihara,et al.  Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  K. Matthay,et al.  Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit , 2014, Intensive Care Medicine.

[8]  M. Matthay.  Resolution of pulmonary edema. Thirty years of progress. , 2014, American journal of respiratory and critical care medicine.

[9]  G. Amerongen,et al.  Plasma Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis* , 2014, Critical care medicine.

[10]  A. Moss.  The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease. , 2013, Cytokine & growth factor reviews.

[11]  Elias K. Loos,et al.  Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage , 2013, PloS one.

[12]  M. Matthay,et al.  Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. , 2013, American journal of respiratory and critical care medicine.

[13]  P. Bono,et al.  Higher angiopoietin-2 and VEGF levels predict shorter EFS and increased non-relapse mortality after pediatric hematopoietic SCT , 2013, Bone Marrow Transplantation.

[14]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[15]  B. Thompson,et al.  Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance* , 2012, Critical care medicine.

[16]  M. Curley,et al.  Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations From the Pediatric Acute Lung Injury Consensus Conference* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[17]  T. Luft,et al.  Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. , 2011, Blood.

[18]  V. V. van Hinsbergh,et al.  THE INTERACTION OF SOLUBLE TIE2 WITH ANGIOPOIETINS AND PULMONARY VASCULAR PERMEABILITY IN SEPTIC AND NONSEPTIC CRITICALLY ILL PATIENTS , 2010, Shock.

[19]  V. V. van Hinsbergh,et al.  Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality , 2009, Intensive Care Medicine.

[20]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[21]  V. V. van Hinsbergh,et al.  The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. , 2009, Expert opinion on therapeutic targets.

[22]  A. Ganser,et al.  Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. , 2008, Blood.

[23]  J. Catravas,et al.  Endothelial pathomechanisms in acute lung injury , 2008, Vascular Pharmacology.

[24]  Y. Kimura,et al.  Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  L. He,et al.  Mesenchymal stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice , 2007, The Journal of pathology.

[26]  J. Gutkind,et al.  Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. , 2008, Developmental cell.

[27]  J. Carcillo,et al.  ADMISSION ANGIOPOIETIN LEVELS IN CHILDREN WITH SEPTIC SHOCK , 2007, Shock.

[28]  D. Stewart,et al.  Competing Interests: This work was , 2022 .

[29]  M. Matthay,et al.  Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation* , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[30]  R. Homer,et al.  Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.

[31]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[32]  D. Christiani,et al.  Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans , 2006, PLoS medicine.

[33]  R. Crystal,et al.  VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema , 2005, European Respiratory Journal.

[34]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[35]  B. Dunmore,et al.  ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1. , 2003, Blood.

[36]  M. Marron,et al.  The Antiinflammatory Endothelial Tyrosine Kinase Tie2 Interacts With a Novel Nuclear Factor-&kgr;B Inhibitor ABIN-2 , 2003, Circulation research.

[37]  M. Matthay,et al.  Alveolar fluid clearance in patients with ARDS: does it make a difference? , 2002, Chest.

[38]  Richard A. Lang,et al.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Thickett,et al.  Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[40]  S. Mandriota,et al.  Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. , 2000, The American journal of pathology.

[41]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[42]  Alain Martinot,et al.  Development of a Pediatric Multiple Organ Dysfunction Score , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[43]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[44]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[45]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[46]  A. Groeneveld,et al.  The 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. , 1996, Critical care medicine.

[47]  U. Ruttimann,et al.  PRISM III: an updated Pediatric Risk of Mortality score. , 1996, Critical care medicine.

[48]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[49]  Thomas N. Sato,et al.  Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Iwama,et al.  Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. , 1993, Biochemical and biophysical research communications.

[51]  J. Rossant,et al.  tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. , 1992, Oncogene.

[52]  J. Partanen,et al.  A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains , 1992, Molecular and cellular biology.

[53]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[54]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.